Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-26T14:40:43.606Z Has data issue: false hasContentIssue false
  • English
  • Français

Facial palsy in individuals with thalidomide embryopathy: frequency and characteristics

Published online by Cambridge University Press:  17 July 2012

L Sjögreen  and
S Kiliaridis
L Sjögreen*
Affiliation:
Mun-H-Center Orofacial Resource Centre for Rare Diseases and Department of Speech Pathology, Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Sweden
S Kiliaridis
Affiliation:
Department of Orthodontics, Dental School, University of Geneva, Switzerland
*
Address for correspondence: Dr Lotta Sjögreen, Mun-H-Center, Odontologen, Medicinaregatan 12 A, SE-413 90 Göteborg, Sweden Fax: + 46 31 750 92 01 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Earlier studies have shown that individuals with thalidomide embryopathy can have skeletal deformities, ear and eye aberrations, and facial palsy. This study aimed to survey the frequency and characteristics of facial palsy in this group of individuals.

Participants:

Thirty-one individuals with thalidomide embryopathy (age range, 45–47 years) and 25 healthy adults (age range, 41–56 years; mean age ± standard deviation, 49 ± 4.2 years).

Main outcome measures:

Voluntary facial movements, lip force and three-dimensional lip motion analysis.

Results and conclusion:

Four of the thalidomide embryopathy individuals (13 per cent) had congenital facial palsy. All four had eye aberrations, three had ear anomalies and one had a limb anomaly. Individuals with thalidomide embryopathy without a clinical diagnosis of facial impairment had significantly weaker lips and more restricted lip mobility than healthy controls. This study contributes to the overall knowledge of thalidomide embryopathy by adding a description of how facial expression can be affected in this condition.

Keywords

ThalidomideEmbryopathiesFacial Palsy
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 126 , Issue 9 , September 2012 , pp. 902 - 906
Copyright
Copyright © JLO (1984) Limited 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Lenz, W. A short history of thalidomide embryopathy. Teratology 1988;38:203–15Google Scholar
2Strömland, K, Miller, MT. Thalidomide embryopathy: revisited 27 years later. Acta Ophthalmol (Copenh) 1993;71:238–45CrossRefGoogle ScholarPubMed
3Ekfeldt, A, Carlsson, GE. Dental status and oral function in an adult group of subjects with thalidomide embryopathy – a clinical and questionnaire study. Acta Odontol Scand 2008;66:300–6CrossRefGoogle Scholar
4Miller, MT, Strömland, K, Ventura, L. Congenital aberrant tearing: a re-look. Trans Am Ophthalmol Soc 2008;106:100–16Google ScholarPubMed
5Ross, BG, Fradet, G, Nedzelski, JM. Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg 1996;114:380–6CrossRefGoogle ScholarPubMed
6Neely, JG, Cherian, NG, Dickerson, CB, Nedzelski, JM. Sunnybrook facial grading system: reliability and criteria for grading. Laryngoscope 2010;120:1038–45Google Scholar
7Schimmel, M, Christou, P, Houstis, O, Herrmann, FR, Kiliaridis, S, Muller, F. Distances between facial landmarks can be measured accurately with a new digital 3-dimensional video system. Am J Orthod Dentofacial Orthop 2010;137:580.e1–10Google Scholar
8Sjögreen, L, Lohmander, A, Kiliaridis, S. Exploring quantitative methods for evaluation of lip function. J Oral Rehabil 2011;38:410–22Google Scholar
9Hägg, M, Olgarsson, M, Anniko, M. Reliable lip force measurement in healthy controls and in patients with stroke: a methodologic study. Dysphagia 2008;23:291–6CrossRefGoogle ScholarPubMed
10Miller, MT, Strömland, K. Ocular motility in thalidomide embryopathy. J Pediatr Ophthalmol Strabismus 1991;28:47–54Google Scholar
11Marques-Dias, MJ, Gonzalez, CH, Rosemberg, S. Möbius sequence in children exposed in utero to misoprostol: neuropathological study of three cases. Birth Defects Res A Clin Mol Teratol 2003;67:1002–7Google Scholar
12Sjögreen, L, Andersson-Norinder, J, Jacobsson, C. Development of speech, feeding, eating, and facial expression in Möbius sequence. Int J Pediatr Otorhinolaryngol 2001;60:197–204Google Scholar
13Strömland, K, Miller, M, Sjögreen, L, Johansson, M, Joelsson, BM, Billstedt, E et al. Oculo-auriculo-vertebral spectrum: associated anomalies, functional deficits and possible developmental risk factors. Am J Med Genet A 2007;143A:1317–25Google Scholar
14Touliatou, V, Fryssira, H, Mavrou, A, Kanavakis, E, Kitsiou-Tzeli, S. Clinical manifestations in 17 Greek patients with Goldenhar syndrome. Genet Couns 2006;17:359–70Google Scholar
15Carvalho, GJ, Song, CS, Vargervik, K, Lalwani, AK. Auditory and facial nerve dysfunction in patients with hemifacial microsomia. Arch Otolaryngol Head Neck Surg 1999;125:209–12Google Scholar
16Blake, KD, Hartshorne, TS, Lawand, C, Dailor, AN, Thelin, JW. Cranial nerve manifestations in CHARGE syndrome. Am J Med Genet A 2008;146A:585–92Google Scholar
17Strömland, K, Sjögreen, L, Johansson, M, Ekman Joelsson, B-M, Miller, M, Danielsson, S et al. CHARGE association in Sweden: malformations and functional deficits. Am J Med Genet A 2005;133A:331–9CrossRefGoogle ScholarPubMed
18Katusic, SK, Beard, CM, Wiederholt, WC, Bergstralh, EJ, Kurland, LT. Incidence, clinical features, and prognosis in Bell's palsy, Rochester, Minnesota, 1968–1982. Ann Neurol 1986;20:622–7CrossRefGoogle ScholarPubMed